Should You Forget Canopy Growth and Buy This Magnificent Cannabis Stock Instead?

Investors successful Canopy Growth (NASDAQ: CGC) person watched the worth of their shares spell up successful fume implicit the past year, arsenic the banal fell by much than 40%. Around 9 years ago, the Canadian cannabis retailer and grower had a marketplace headdress of astir $1.5 billion, making it the largest institution successful its segment. At its peaks, successful 2019 and 2021, it was worthy much than $15 billion. Today, its marketplace headdress has tumbled to conscionable nether $400 million, and it hasn't had a profitable 4th since Q2 2021.

By contrast, if you're looking to put successful a plant-touching cannabis institution that's really profitable and amended prepared for the semipermanent maturation the manufacture is expecting, determination is simply a coagulated option. Chicago-based Green Thumb Industries (OTC: GTBIF) is connected way for its sixth consecutive twelvemonth of affirmative net per stock (EPS). Let's comparison the cases for Canopy Growth versus Green Thumb Industries.

Will AI make the world's archetypal trillionaire? Our squad conscionable released a study connected the 1 little-known company, called an "Indispensable Monopoly" providing the captious exertion Nvidia and Intel some need. Continue »

The champion statement for buying shares of Canopy Growth is that it seems to beryllium improving its bottom-line performance. And with the banal trading astatine conscionable implicit $1 a share, it whitethorn beryllium worthy taking a flier connected the company.

In its fiscal 2026 3rd quarter, which ended Dec. 31, it reported gross of $90.4 billion, up 5% twelvemonth implicit year. It besides trimmed its nett nonaccomplishment by 49%, resulting successful a nonaccomplishment of $0.18 per share.

The institution besides narrowed its nett semipermanent indebtedness by 25% to $225 million. To bash that, however, it has issued a batch of caller stock, diluting the worth of the banal for its anterior shareholders. Over the past twelvemonth alone, the fig of shares outstanding has accrued by 142%. Canopy has operations successful Canada, Germany, and Australia. Canopy USA's 2024 acquisition of Acreage Holdings gives it a toehold successful the increasing U.S. cannabis market.

Green Thumb Industries is 1 of the larger multi-state operators (MSOs) successful the U.S. cannabis sector. As of the extremity of the 3rd quarter, it had 108 dispensaries and 20 manufacturing facilities crossed 14 states. If cannabis is reclassified arsenic a Schedule III substance, arsenic appears apt to hap sometime successful the adjacent 2 years, the institution volition go adjacent much profitable based connected tax-related reasons alone.

As it stands now, with marijuana considered a Schedule I cause (the aforesaid classification arsenic heroin), cannabis companies cannot instrumentality modular concern deductions. If and erstwhile that changes, MSOs successful the U.S. volition benefit. One survey by Whitney Economics recovered that U.S. cannabis companies paid an further $2.3 cardinal successful taxes successful 2024 due to the fact that the cause was inactive a Schedule I drug. Rescheduling volition springiness steadfast companies specified arsenic Green Thumb the quality to put much successful growth.